enlon-plus- edrophonium chloride and atropine sulfate injection United States - English - NLM (National Library of Medicine)

enlon-plus- edrophonium chloride and atropine sulfate injection

baxter healthcare corporation - edrophonium chloride (unii: qo611ksm5p) (edrophonium - unii:), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - injection - 10 mg in 1 ml - enlon-plus (edrophonium chloride, usp and atropine sulfate, usp) injection is recommended as a reversal agent or antagonist of nondepolarizing neuromuscular blocking agents. it is not effective against depolarizing neuromuscular blocking agents. it is also useful if used adjunctively in the treatment of respiratory depression caused by curare overdosage. the appropriateness of the specific fixed ratio of edrophonium and atropine contained in enlon-plus has not been evaluated in myasthenia gravis. therefore, enlon-plus is not recommended for use in the differential diagnosis of this condition. enlon-plus (edrophonium chloride, usp and atropine sulfate, usp) injection is not to be used in patients with known hypersensitivity to either

ENLON PLUS edrophonium chloride and atropine sulfate injection solution United States - English - NLM (National Library of Medicine)

enlon plus edrophonium chloride and atropine sulfate injection solution

mylan institutional llc - edrophonium chloride (unii: qo611ksm5p) (edrophonium - unii:70fp3jly7n) - edrophonium chloride 10 mg in 1 ml

ENLON edrophonium chloride injection solution United States - English - NLM (National Library of Medicine)

enlon edrophonium chloride injection solution

mylan institutional llc - edrophonium chloride (unii: qo611ksm5p) (edrophonium - unii:70fp3jly7n) - edrophonium chloride 10 mg in 1 ml

enlon- Edrophonium chloride injection United States - English - NLM (National Library of Medicine)

enlon- edrophonium chloride injection

baxter healthcare corporation - edrophonium chloride (unii: qo611ksm5p) (edrophonium cation - unii:70fp3jly7n) - injection - 10 mg in 1 ml - enlon is recommended for the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. it may also be used for evaluating emergency treatment in myasthenic crises. because of its brief duration of action, it is not recommended for maintenance therapy in myasthenia gravis. enlon is also useful whenever a curare antagonist is needed to reverse the neuromuscular block produced by curare, tubocurarine, gallamine triethiodide or dimethyl-tubocurarine. it is not effective against decamethonium bromide and succinylcholine chloride. it may be used adjunctively in the treatment of respiratory depression caused by curare overdosage. known hypersensitivity to anticholinesterase agents; intestinal and urinary obstructions of mechanical type.

Hydrophobic Luer filter Australia - English - Department of Health (Therapeutic Goods Administration)

hydrophobic luer filter

merck life science pty ltd - 60833 - hydrophobic luer filter - sterile venting of vials and bottles in pharmacy applications

Hydrophobic Luer filter Australia - English - Department of Health (Therapeutic Goods Administration)

hydrophobic luer filter

global life sciences solutions australia pty ltd - 60833 - hydrophobic luer filter - to be attached to equipment during a medical/surgical procedure and/or to a needle during drug preparation (i.e., vial venting) to prevent the transfer of microbes, particulates and aerosols while allowing passage of air/gas